Bio Essence Corporation
BIOE
$0.206
-$0.008-3.74%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -27.60K | -1.20M | -305.50K | 133.90K | -193.70K |
| Total Depreciation and Amortization | 300.00 | 100.00 | 300.00 | 500.00 | -30.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.60K | 1.23M | 215.50K | -259.50K | 62.40K |
| Change in Net Operating Assets | 434.70K | 325.70K | 105.00K | -46.60K | -42.50K |
| Cash from Operations | 423.10K | 357.10K | 15.30K | -171.60K | -204.10K |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -100.00 | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00 | -- | -- | -- | -87.90K |
| Total Debt Issued | -- | -185.20K | -5.50K | 190.70K | 331.30K |
| Total Debt Repaid | -451.50K | -151.60K | -300.00 | -9.70K | 38.30K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | -9.30K | -77.60K |
| Cash from Financing | -451.50K | -336.80K | -5.80K | 171.60K | 292.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28.60K | 20.30K | 9.50K | 0.00 | 100.00 |